Cargando…

Assessment of a Novel Automatic Real-Time PCR Assay on the Cobas 4800 Analyzer as a Screening Platform for Hepatitis C Virus Genotyping in Clinical Practice: Comparison with Massive Sequencing

The unequivocal identification of hepatitis C virus (HCV) subtypes 1a/1b and genotypes 2 to 6 is required for optimizing the effectiveness of interferon-free, direct-acting antiviral therapies. We compared the performance of a new real-time HCV genotyping assay used on the Cobas 4800 system (C4800)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nieto-Aponte, Leonardo, Quer, Josep, Ruiz-Ripa, Alicia, Tabernero, David, Gonzalez, Carolina, Gregori, Josep, Vila, Marta, Asensio, Miriam, Garcia-Cehic, Damir, Ruiz, Gerardo, Chen, Qian, Ordeig, Laura, Llorens, Meritxell, Saez, Montserrat, Esteban, Juan I., Esteban, Rafael, Buti, Maria, Pumarola, Tomas, Rodriguez-Frias, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2017
Materias:	Virology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5277520/ https://www.ncbi.nlm.nih.gov/pubmed/27927921 http://dx.doi.org/10.1128/JCM.01960-16

Ejemplares similares

New real-time-PCR method to identify single point mutations in hepatitis C virus
por: Chen, Qian, et al.
Publicado: (2016)

Stability Study of Cervical Specimens Collected by Swab and Stored Dry Followed by Human Papillomavirus DNA Detection Using the cobas 4800 Test
por: Lin, Chun-Qing, et al.
Publicado: (2017)

Baseline hepatitis C virus resistance-associated substitutions present at frequencies lower than 15% may be clinically significant
por: Perales, Celia, et al.
Publicado: (2018)

Significant Improvement in Diagnosis of Hepatitis C Virus Infection by a One-Step Strategy in a Central Laboratory: an Optimal Tool for Hepatitis C Elimination?
por: López-Martínez, Rosa, et al.
Publicado: (2019)

Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening
por: Saville, Marion, et al.
Publicado: (2019)

Pipeline for specific subtype amplification and drug resistance detection in hepatitis C virus
por: Soria, María Eugenia, et al.
Publicado: (2018)

Clinical Application of Estimating Hepatitis B Virus Quasispecies Complexity by Massive Sequencing: Correlation between Natural Evolution and On-Treatment Evolution
por: Homs, Maria, et al.
Publicado: (2014)

Utility of the Cobas(®) Plasma Separation Card as a Sample Collection Device for Serological and Virological Diagnosis of Hepatitis C Virus Infection
por: Velásquez-Orozco, Fernando, et al.
Publicado: (2021)

Equivalent Performance of the Cobas(®) Cdiff Test for Use on the Cobas(®) Liat(®) System and the Cobas(®) 4800 System
por: Garg, Sachin K, et al.
Publicado: (2017)

Deep-sequencing study of HCV G4a resistance-associated substitutions in Egyptian patients failing DAA treatment
por: Amer, Fatma, et al.
Publicado: (2019)

Study of Quasispecies Complexity and Liver Damage Progression after Liver Transplantation in Hepatitis C Virus Infected Patients
por: Llorens-Revull, Meritxell, et al.
Publicado: (2021)

Cobas 4800 HPV detection in cervical samples of Polish women
por: Smolarz, Beata, et al.
Publicado: (2019)

Whole-genome characterization and resistance-associated substitutions in a new HCV genotype 1 subtype
por: von Massow, Georg, et al.
Publicado: (2019)

An HIV Diagnostic Testing Algorithm Using the cobas HIV-1/HIV-2 Qualitative Assay for HIV Type Differentiation and Confirmation
por: Duncan, Dana, et al.
Publicado: (2021)

Clinical Performance of the Point-of-Care cobas Liat for Detection of SARS-CoV-2 in 20 Minutes: a Multicenter Study
por: Hansen, Glen, et al.
Publicado: (2021)

Ultra-Deep Pyrosequencing (UDPS) Data Treatment to Study Amplicon HCV Minor Variants
por: Gregori, Josep, et al.
Publicado: (2013)

Detection of SARS-CoV-2 infection in asymptomatic populations using the DiaSorin molecular Simplexa and Roche Cobas EUA assays
por: Antonara, Stella, et al.
Publicado: (2022)

Diagnosis and Monitoring of Hepatitis B Virus Infection Using the Cobas(®) HBV Test for Use on the Cobas(®) 4800 System
por: Ortonne, Valérie, et al.
Publicado: (2021)

Complex Genotype Mixtures Analyzed by Deep Sequencing in Two Different Regions of Hepatitis B Virus
por: Caballero, Andrea, et al.
Publicado: (2015)

Clinical Evaluation of the cobas SARS-CoV-2 Test and a Diagnostic Platform Switch during 48 Hours in the Midst of the COVID-19 Pandemic
por: Poljak, Mario, et al.
Publicado: (2020)

Separation of Plasma from Whole Blood by Use of the cobas Plasma Separation Card: a Compelling Alternative to Dried Blood Spots for Quantification of HIV-1 Viral Load
por: Carmona, Sergio, et al.
Publicado: (2019)

Multicenter Evaluation of Two Next-Generation HIV-1 Quantitation Assays, Aptima Quant Dx and Cobas 6800, in Comparison to the RealTime HIV-1 Reference Assay
por: Wiesmann, Frank, et al.
Publicado: (2018)

Evidence of an Exponential Decay Pattern of the Hepatitis Delta Virus Evolution Rate and Fluctuations in Quasispecies Complexity in Long-Term Studies of Chronic Delta Infection
por: Homs, Maria, et al.
Publicado: (2016)

Prevalence of high-risk human papillomavirus by cobas 4800 HPV test in urban Peru
por: Iwasaki, Ricardo, et al.
Publicado: (2014)

Ultra-Deep Pyrosequencing Detects Conserved Genomic Sites and Quantifies Linkage of Drug-Resistant Amino Acid Changes in the Hepatitis B Virus Genome
por: Rodriguez-Frías, Francisco, et al.
Publicado: (2012)

Performance of the New Aptima HCV Quant Dx Assay in Comparison to the Cobas TaqMan HCV2 Test for Use with the High Pure System in Detection and Quantification of Hepatitis C Virus RNA in Plasma or Serum
por: Schalasta, Gunnar, et al.
Publicado: (2016)

Comparison of the ID Now Influenza A & B 2, Cobas Influenza A/B, and Xpert Xpress Flu Point-of-Care Nucleic Acid Amplification Tests for Influenza A/B Virus Detection in Children
por: Kanwar, Neena, et al.
Publicado: (2020)

Bioinformatic Tools for NGS-Based Metagenomics to Improve the Clinical Diagnosis of Emerging, Re-Emerging and New Viruses
por: Ibañez-Lligoña, Marta, et al.
Publicado: (2023)

Quasispecies Fitness Partition to Characterize the Molecular Status of a Viral Population. Negative Effect of Early Ribavirin Discontinuation in a Chronically Infected HEV Patient
por: Gregori, Josep, et al.
Publicado: (2022)

Analysis of hepatitis B virus preS1 variability and prevalence of the rs2296651 polymorphism in a Spanish population
por: Casillas, Rosario, et al.
Publicado: (2018)

Sputasol (Dithiothreitol 0.54%) Improves the Detection of Human Papillomaviruses Using the Cobas 4800 System
por: Wang, Qing-Yong, et al.
Publicado: (2017)

Application of the Cobas 4800 System for the Detection of High-Risk Human Papillomavirus in 5650 Asymptomatic Women
por: Wang, Shanyun, et al.
Publicado: (2020)

High-Risk Human Papillomavirus Detection via Cobas(®) 4800 and REBA HPV-ID(®) Assays
por: Liewchalermwong, Sasiprapa, et al.
Publicado: (2022)

Evidence for positive selection of hepatitis A virus antigenic variants in vaccinated men-having-sex-with men patients: Implications for immunization policies
por: Sabrià, Aurora, et al.
Publicado: (2018)

Hepatitis B Virus Variants with Multiple Insertions and/or Deletions in the X Open Reading Frame 3′ End: Common Members of Viral Quasispecies in Chronic Hepatitis B Patients
por: García-García, Selene, et al.
Publicado: (2022)

Prevalence of Hepatitis C Virus Infection, Genotypes and Subtypes in Migrants from Pakistan in Barcelona, Spain
por: Dopico, Eva, et al.
Publicado: (2022)

Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients
por: Andrés, Cristina, et al.
Publicado: (2020)

Cross-sectional evaluation of circulating hepatitis B virus RNA and DNA: Different quasispecies?
por: Garcia-Garcia, Selene, et al.
Publicado: (2021)

An Evaluation of the Cobas4800 HPV Test on Cervico-Vaginal Specimens in Liquid versus Solid Transport Media
por: Luo, Hongxue, et al.
Publicado: (2016)

Consistency evaluation of Liferiver, Yaneng, Darui, and the Cobas 4800 test for high‐risk human papillomavirus screening
por: Wang, Mengmeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2vniftq9jnobkvol3d5h5va369